Dr. Alexander Kretschmer on next steps for ExoDx Prostate test


Dr. Alexander Kretschmer, MD, discusses the next steps with research and clinical use of the ExoDx Prostate test (EPI test). The non-invasive, urine-based genomic test is a risk assessment tool that helps physicians and patients determine whether a prostate biopsy is necessary when PSA screening provides an ambiguous result

Kretschmer is an assistant professor of Urology at Ludwig-Maximilians-University Munich.

Related Videos
Dr. Mehmet Asim Bilen in an interview with Urology Times
blurred clinic hallway
Dr. Adam Weiner in an interview with Urology Times
Dr. Sagar Patel in an interview with Urology Times
Related Content
© 2024 MJH Life Sciences

All rights reserved.